Search

• Written by: P.M. Forde ×
• Topic: Mesothelioma ×
• Clear filters

1 result for “Ford Motor Company”

1. Medical study · Medical research · 2022

   Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma-a phase 3 randomised trial

   This article was a protocol: it described a planned trial, DREAM3R, and reported no treatment results. DREAM3R was designed as an international, open-label, randomised phase 3 trial at sites in Australia, New Zealand and the USA. It aimed to enrol…